DV Biomed Current Valuation vs. Price To Earning
| 6539 Stock | TWD 66.60 0.20 0.30% |
For DV Biomed profitability analysis, we use financial ratios and fundamental drivers that measure the ability of DV Biomed to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well DV Biomed Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between DV Biomed's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of DV Biomed Co over time as well as its relative position and ranking within its peers.
6539 |
DV Biomed Price To Earning vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining DV Biomed's current stock value. Our valuation model uses many indicators to compare DV Biomed value to that of its competitors to determine the firm's financial worth. DV Biomed Co is the top company in current valuation category among its peers. It also is number one stock in price to earning category among its peers . The ratio of Current Valuation to Price To Earning for DV Biomed Co is about 272,794,663 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the DV Biomed's earnings, one of the primary drivers of an investment's value.6539 Current Valuation vs. Competition
DV Biomed Co is the top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Drug Manufacturers—Specialty & Generic industry is presently estimated at about 69.44 Billion. DV Biomed holds roughly 3.68 Billion in current valuation claiming about 5% of equities under Drug Manufacturers—Specialty & Generic industry.
6539 Price To Earning vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
DV Biomed |
| = | 3.68 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
DV Biomed |
| = | 13.49 X |
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
6539 Price To Earning Comparison
DV Biomed is currently under evaluation in price to earning category among its peers.
DV Biomed Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in DV Biomed, profitability is also one of the essential criteria for including it into their portfolios because, without profit, DV Biomed will eventually generate negative long term returns. The profitability progress is the general direction of DV Biomed's change in net profit over the period of time. It can combine multiple indicators of DV Biomed, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
DV Biomed Co., Ltd. manufactures and sells medical-grade skin care products in Taiwan and internationally. The company was founded in 2011 and is based in Taipei, Taiwan. UnicoCell operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan OTC Exchange.
6539 Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on DV Biomed. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of DV Biomed position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the DV Biomed's important profitability drivers and their relationship over time.
Use DV Biomed in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DV Biomed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DV Biomed will appreciate offsetting losses from the drop in the long position's value.DV Biomed Pair Trading
DV Biomed Co Pair Trading Analysis
The ability to find closely correlated positions to DV Biomed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DV Biomed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DV Biomed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DV Biomed Co to buy it.
The correlation of DV Biomed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DV Biomed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DV Biomed moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DV Biomed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your DV Biomed position
In addition to having DV Biomed in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Emerging Markets Funds Thematic Idea Now
Emerging Markets Funds
Fund or Etfs that invest in markets of developing countries. The Emerging Markets Funds theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Emerging Markets Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for 6539 Stock Analysis
When running DV Biomed's price analysis, check to measure DV Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DV Biomed is operating at the current time. Most of DV Biomed's value examination focuses on studying past and present price action to predict the probability of DV Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DV Biomed's price. Additionally, you may evaluate how the addition of DV Biomed to your portfolios can decrease your overall portfolio volatility.